Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 USD | +1.90% | +9.41% | -55.94% |
15/05 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
14/05 | Top Midday Decliners | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.94% | 10Cr | |
+7.01% | 21TCr | |
+11.01% | 19TCr | |
+19.20% | 14TCr | |
+30.79% | 11TCr | |
+1.48% | 6.47TCr | |
+13.95% | 5.3TCr | |
-0.16% | 4.98TCr | |
-6.20% | 3.83TCr | |
+0.91% | 3.59TCr |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Transcript : Akoya Biosciences, Inc., Q1 2023 Earnings Call, May 08, 2023